Clinic
Jackson County Hospital District
Jackson County Hospital District was paid $16.75M by Medicaid between Jan 2018 and Dec 2024, across 184 billing codes. Its largest line is 99283, emergency room visit (moderate) — 30% of everything it billed.
33Billing provider infoJACKSON COUNTY HOSPITAL DISTRICT
MARIANNA, FL 32446
MARIANNA, FL 32446
33aNPI1538108725assigned 06/05/2006
33bProvider typeRural Health Clinic/Center
28Total paid$16.75M
24GClaims433,405
24DCodes billed184
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rural Health Clinic/Center providers in Florida
Rank by total paid#1 of 76
Median peer was paid$164K
This provider vs. median102×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,238 | $360K | |
| 2019 | 63,586 | $1.95M | |
| 2020 | 68,301 | $1.72M | |
| 2021 | 78,104 | $2.80M | |
| 2022 | 89,245 | $4.28M | |
| 2023 | 69,256 | $3.61M | |
| 2024incomplete | 40,675 | $2.02M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 30% | 33,821 | 30,117 | $5.02M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 17,171 | 14,668 | $2.38M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 8,819 | 7,304 | $1.96M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.0% | 3,336 | 3,069 | $507K |
| G0378 | Hospital observation service, per hour | 2.2% | 4,381 | 2,567 | $366K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.0% | 5,391 | 1,211 | $340K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.0% | 919 | 741 | $334K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.8% | 15,663 | 11,764 | $305K |
| 87631 | 1.8% | 7,244 | 6,293 | $296K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.8% | 4,253 | 3,533 | $295K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.7% | 2,859 | 2,316 | $286K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.6% | 2,106 | 496 | $267K |
172 more codes
| 84703 | 1.3% | 7,629 | $213K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 3,224 | $206K |
| 87430 | 1.1% | 6,568 | $189K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1.0% | 2,256 | $173K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 1.0% | 2,289 | $171K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 714 | $161K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,534 | $154K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 7,963 | $135K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 30,663 | $121K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,247 | $110K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,433 | $106K |
| 81001 | <1% | 22,463 | $104K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,117 | $103K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,448 | $100K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,738 | $97K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 8,551 | $88K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,025 | $85K |
| 87449 | <1% | 4,102 | $85K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 7,609 | $82K |
| 80053 | Comprehensive metabolic panel | <1% | 11,861 | $70K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,308 | $68K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 8,331 | $67K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,016 | $57K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 25 | $56K |
| 84484 | <1% | 5,626 | $55K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 6,832 | $52K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,076 | $50K |
| 83735 | <1% | 8,822 | $45K | |
| 97161 | <1% | 318 | $45K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 422 | $45K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,403 | $45K |
| 80076 | <1% | 9,427 | $44K | |
| 86900 | <1% | 708 | $44K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 28 | $43K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 430 | $42K |
| 73630 | <1% | 787 | $39K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,266 | $39K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,548 | $36K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,464 | $36K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,954 | $36K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 969 | $34K |
| 71045 | Radiologic examination, chest; single view | <1% | 5,355 | $32K |
| 73564 | <1% | 782 | $30K | |
| 76830 | Ultrasound, transvaginal | <1% | 316 | $29K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,234 | $28K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,026 | $28K |
| 96367 | <1% | 380 | $28K | |
| 73610 | <1% | 505 | $28K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,760 | $24K |
| 80047 | <1% | 4,401 | $24K | |
| 83690 | <1% | 4,782 | $23K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,493 | $20K |
| 74018 | <1% | 734 | $20K | |
| 87186 | <1% | 5,197 | $19K | |
| 73030 | <1% | 383 | $17K | |
| 73110 | <1% | 246 | $17K | |
| 73130 | <1% | 349 | $17K | |
| 87077 | <1% | 6,557 | $17K | |
| 83605 | <1% | 3,480 | $16K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,701 | $15K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 104 | $15K |
| 83880 | <1% | 1,817 | $15K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,404 | $13K |
| 87420 | <1% | 266 | $13K | |
| 86901 | <1% | 707 | $13K | |
| 87040 | <1% | 2,018 | $12K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 960 | $12K |
| 85610 | <1% | 2,358 | $12K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,178 | $12K |
| 87210 | <1% | 424 | $12K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,082 | $12K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 182 | $11K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 43 | $11K |
| 96376 | <1% | 1,223 | $11K | |
| 87070 | <1% | 1,079 | $10K | |
| 84702 | <1% | 662 | $10K | |
| 74022 | <1% | 517 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,553 | $10K |
| 99307 | <1% | 982 | $9K | |
| G0379 | Direct admission of patient for hospital observation care | <1% | 677 | $9K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 629 | $9K |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 1,200 | $8K |
| 84439 | <1% | 3,896 | $7K | |
| 87081 | <1% | 4,386 | $7K | |
| 80061 | Lipid panel | <1% | 5,521 | $7K |
| 85730 | <1% | 816 | $7K | |
| 80164 | <1% | 1,458 | $7K | |
| 72110 | <1% | 127 | $6K | |
| 76801 | <1% | 74 | $6K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,508 | $6K |
| 76536 | <1% | 56 | $6K | |
| 82607 | <1% | 2,390 | $6K | |
| 84145 | <1% | 292 | $5K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 611 | $5K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,350 | $5K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 580 | $5K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 548 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,449 | $5K |
| 82728 | <1% | 1,881 | $5K | |
| 82140 | <1% | 813 | $4K | |
| 85027 | <1% | 1,464 | $4K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 679 | $4K |
| 77080 | <1% | 214 | $4K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 400 | $4K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 32 | $4K |
| 82746 | <1% | 2,068 | $4K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 606 | $3K |
| 76641 | <1% | 47 | $3K | |
| 83540 | <1% | 1,939 | $3K | |
| 86850 | <1% | 220 | $3K | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 275 | $2K |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 297 | $2K |
| 73502 | <1% | 98 | $2K | |
| 83883 | <1% | 94 | $2K | |
| 82378 | <1% | 730 | $2K | |
| 96368 | <1% | 22 | $2K | |
| 83550 | <1% | 1,750 | $2K | |
| 83615 | <1% | 1,724 | $2K | |
| 84153 | <1% | 730 | $2K | |
| 82150 | <1% | 273 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 6,029 | $2K |
| 72050 | <1% | 28 | $2K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 23 | $2K |
| 93971 | <1% | 47 | $2K | |
| 86803 | <1% | 579 | $2K | |
| 74019 | <1% | 46 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 69 | $1K |
| 77066 | Tomosynthesis, mammo | <1% | 13 | $1K |
| 87634 | <1% | 18 | $1K | |
| 82803 | <1% | 112 | $1K | |
| 85379 | <1% | 368 | $976.35 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 540 | $818.86 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 333 | $800.32 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 579 | $748.02 |
| 84550 | <1% | 940 | $742.14 | |
| 71101 | <1% | 19 | $682.59 | |
| 84100 | <1% | 63 | $646.96 | |
| 82550 | <1% | 250 | $550.58 | |
| 82570 | <1% | 458 | $536.30 | |
| 82043 | <1% | 532 | $488.41 | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 28 | $481.54 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 161 | $380.89 |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 26 | $372.63 |
| 86704 | <1% | 216 | $341.52 | |
| 80177 | <1% | 48 | $339.96 | |
| 90715 | <1% | 123 | $334.64 | |
| 73140 | <1% | 12 | $314.66 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 800 | $297.81 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 177 | $275.76 |
| 84165 | <1% | 127 | $267.41 | |
| 82024 | <1% | 62 | $216.68 | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | <1% | 34 | $215.67 |
| 86141 | <1% | 77 | $151.86 | |
| 85652 | <1% | 44 | $120.59 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 224 | $108.03 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 185 | $95.69 |
| 82533 | <1% | 45 | $77.66 | |
| 84146 | <1% | 23 | $25.32 | |
| 80184 | <1% | 12 | $22.96 | |
| 85046 | <1% | 15 | $9.27 | |
| 82232 | <1% | 55 | $5.97 | |
| 82784 | <1% | 147 | $2.43 | |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | <1% | 17 | $1.00 |
| 82270 | <1% | 16 | $1.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 54 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 116 | $0.00 |
| 73080 | 0% | 52 | $0.00 | |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 0% | 17 | $0.00 |
| 29125 | 0% | 24 | $0.00 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 15 | $0.00 |
| 97010 | 0% | 74 | $0.00 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCONNOLLY, KELLY (CFO)
| Provider | Location | Paid |
|---|---|---|
| Er Physician Group at Jackson Hospital | Marianna, FL | $3.22M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.